936555-82-7

Upstream product

• 162012-70-6 4-chloro-7-fluoro-6-nitroquinazoline 

Downstream Products

• 936555-84-9 N-{2-[4-(4-bromo-2-fluoro-phenylamino)-6-nitro-quinazolin-7-yloxy]-ethyl}-acetamide 
• 936556-20-6 N-{2-[4-(4-bromo-2-fluoro-phenylamino)-6-nitro-quinazolin-7-yloxy]-ethyl}-propionylamide 
• 936556-00-2 cyclopropanecarboxylic acid {2-[4-(4-bromo-2-fluoro-phenylamino)-6-nitro-quinazolin-7-yloxy]-ethyl}-amide 
• 936556-13-7 N-{2-[4-(4-bromo-2-fluoro-phenylamino)-6-nitro-quinazolin-7-yloxy]-ethyl}-2-dimethylamino-acetamide 
• 936555-83-8 [7-(2-amino-ethoxy)-6-nitro-quinazolin-4-yl]-(4-bromo-2-fluoro-phenyl)-amine 

Relevant academic research and scientific papers

QUINAZOLINE DERIVATIVES AS A MULTIPLEX INHIBITOR AND METHOD FOR THE PREPARATION THEREOF

The present invention relates to a novel quinazoline derivative and a pharmaceutically acceptable salt thereof as a multiplex inhibitor, a method for the preparation thereof, and a pharmaceutical composition and a therapeutic composition comprising same as an active ingredient. The inventive quinazoline derivative as a multiplex inhibitor can selectively and effectively inhibit diseases caused by the overactivity of a tyrosine kinase.